SOD1 and hypertensive disorder: Preclinical studies have shown a genetic deletion of antioxidant enzymes (e.g., SOD, GPx) inducing HTN in mice (Carlström et al., 2010), whereas human data led to elevated OS biomarkers (e.g., F2-isoprostanes) preceding HTN onset in normotensive individuals (Rodrigo et al., 2021).